Risk Disclosure in Prodromal Parkinson's Disease von Karagianis, James L.

Volltext

Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature von Karagianis, JL, Phillips, LC, Hogan, KP, LeDrew, KK

Volltext

Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up von Karagianis, James L., LeDrew, Kellie K., Walker, Daniel J.

Volltext

Patient Volume, Human Resource Levels, and Attrition From HIV Treatment Programs in Central Mozambique von Lambdin, Barrot H, Micek, Mark A, Koepsell, Thomas D, Hughes, James P, Sherr, Kenneth, Pfeiffer, James, Karagianis, Marina, Lara, Joseph, Gloyd, Stephen S, Stergachis, Andy

Volltext

Re: Neuroleptic Malignant Syndrome Associated with Quetiapine von Karagianis, James, Phillips, Leslie, Hogan, Kevin, LeDrew, Kellie

Volltext